The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "oxycodone"

Search results for: oxycodone

FDA to Review Abuse-Deterrent Oxycodone Capsule

May 18, 2018 • By Michele B. Kaufman, PharmD, BCGP

FDA to Review Abuse-Deterrent Oxycodone Capsule In June, the FDA will discuss the New Drug Application for Remoxy ER at an Advisory Committee meeting. Remoxy ER is a 12-hour, abuse-deterrent, extended-release oxycodone in a capsule formulation.1 The capsule contains a sticky, thick, high-viscosity formulation to deter unapproved drug administration routes, including injection, smoking or snorting…. [Read More]

Filed Under: Drug Updates Tagged With: adalimumab, NSAIDs, Oxycodone, plaque psoriasis, tildrakizumab-asmn

FDA to Review Abuse Deterrent Oxycodone Capsule & More

April 11, 2018 • By Michele B. Kaufman, PharmD, BCGP

The FDA will discuss a New Drug Application for Remoxy ER during an upcoming advisory committee meeting and recently approved tildrakizumab-asmn to treat adults with plaque psoriasis…... [Read More]

Filed Under: Analgesics, Drug Updates Tagged With: FDA, Remoxy ER, tildrakizumab-asmn, U.S. Food and Drug Administration (FDA)

FDA to Review Immediate-Release Oxycodone; Plus NICE Recommends Secukinumab

May 1, 2017 • By Michele B. Kaufman, PharmD, BCGP

A new formulation of oxycodone in 10 and 15 mg doses is being reviewed by the FDA for treating pain…... [Read More]

Filed Under: Analgesics, Biologics & Biosimilars, Drug Updates Tagged With: FDA, Food and Drug Administration, Opioids, Psoriatic Arthritis, secukinumab

Oxycodone Capsules Put on Hold; Clinical Trials for Lupus Nephritis & SLE Therapies

November 25, 2015 • By Michele B. Kaufman, PharmD, BCGP

Due to a lawsuit, the FDA has issued only tentative approval for an extended-release oxycodone capsule. Obinutuzumab is in clinical trials for lupus nephritis, and subcutaneous belimumab is being tested for SLE…... [Read More]

Filed Under: Analgesics, Biologics & Biosimilars, Drug Updates Tagged With: belimumab, Lupus nephritis, obinutuzumab, Oxycodone, SLE, systemic lupus erythematosus (SLE)

Rituximab for RA Is Safe Long Term, Plus Oxycodone Update

September 30, 2015 • By Michele B. Kaufman, PharmD, BCGP

Rituximab was evaluated and found safe as a long-term RA therapy. Also, FDA Advisory Committees voted on oxycodone therapies at a joint meeting.... [Read More]

Filed Under: Analgesics, Biologics & Biosimilars, Drug Updates Tagged With: analgesic, FDA, Food and Drug Administration, Oxycodone, Rheumatoid Arthritis (RA), rituximab

Colchicine: An Ancient Drug with Modern Uses

August 11, 2021 • By Ibrahem Salloum, MD, & Deepan S. Dalal, MD, MPH

Discovered more than 3,000 years ago, colchicine is one of the oldest drugs still in use today. Like most old remedies, colchicine is a chemical substance found in many plants, most notably in colchicum autumnale, known as wild saffron or autumn crocus. It was mentioned in the oldest Egyptian medical text, Ebers Papyrus (circa 1550… [Read More]

Filed Under: Drug Updates Tagged With: anti­inflammatory, Colchicine, drug treatment, Gout, Gout Resource Center, inflammation

Yao Syndrome: A Case Report & Clinical Review

November 12, 2020 • By Peter Gorevic, MD, & Qingping Yao, MD, PhD

Mattew - Bilder und mehr / shutterstock.com

Case Presentation History of present illness A 66-year-old white woman presented with unexplained, recurrent episodes of high fever, abdominal pain, rash and arthralgias occurring over the previous three years. During typical episodes, the patient experienced flu-like symptoms, followed by fever, abdominal pain and non-bloody diarrhea without tenesmus. Her temperatures were 101–103ºF, with chills lasting up… [Read More]

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: case report, NOD2-associated auto­inflammatory disease, Yao Syndrome

High Opioid Prescription Rates Seen in Emergency Department-Treated Gout

November 2, 2020 • By Kurt Ullman

Acute gout can be very painful, causing patients to seek treatment in the emergency department. A retrospective study of pain interventions for gout in Rhode  Island found that nearly 30% of patients received prescriptions for opioid medications over 30 months. Of these prescriptions, over 80% were for patients who had never been exposed to opioids… [Read More]

Filed Under: Analgesics, Conditions, Crystal Arthritis Tagged With: Gout, Gout Resource Center, opioid crisis

Opioids Commonly Prescribed for Gout Attacks

July 9, 2019 • By Reuters Staff

NEW YORK (Reuters Health)—Nearly three in 10 patients seeking care at the emergency department (ED) for acute gout will be discharged with a prescription for opioids, new research shows. “Our study suggests a high use of prescription opioid in patients discharged from the ED with a diagnosis of gout, a condition that can be managed… [Read More]

Filed Under: Conditions, Crystal Arthritis Tagged With: Arthritis Care & Research, Emergency Department, Gout, opioid, Pain, Pain Management

The Benefits of Blood Money: OxyContin & Ethics

March 18, 2019 • By Philip Seo

On Feb. 9, 2019, protesters gathered at the Guggenheim Museum in New York City to lead a march down Fifth Avenue to the Metropolitan Museum of Art.1 As a general rule, news from the world of art is not a topic discussed in these pages, but if you indulge me for just a little bit… [Read More]

Filed Under: Ethics, Opinion, Rheuminations Tagged With: Arthur M. Sackler Foundation, Dr. Mortimer and Theresa Sackler Foundation, opioid crisis, opioid use disorders, OxyContin, Purdue Pharma, Raymond and Beverly Sackler Foundation

  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)